Published in J Thorac Oncol on February 01, 2010
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. J Clin Oncol (2016) 1.75
Pathological upstaging and treatment strategy of clinical stage I small cell lung cancer following surgery. J Thorac Dis (2017) 1.38
Lung cancer surgery: an up to date. J Thorac Dis (2013) 0.92
Surgery for limited stage small cell lung cancer: time to fish or cut bait. J Thorac Oncol (2010) 0.91
Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation. Radiat Oncol (2014) 0.86
Surgery in limited-disease small-cell lung cancer. Lung India (2012) 0.85
Treatment for small cell lung cancer, where are we now?-a review. Transl Lung Cancer Res (2016) 0.84
Surgical intervention for small-cell lung cancer: what is the surgical role? Gen Thorac Cardiovasc Surg (2012) 0.83
Relevance of an incidental chest finding. Lung India (2012) 0.82
A decade of advances in treatment of early-stage lung cancer. Clin Chest Med (2011) 0.82
Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpy-detected patients with others. World J Surg Oncol (2013) 0.81
Nomogram prediction for the survival of the patients with small cell lung cancer. J Thorac Dis (2017) 0.75
Management of small-cell lung cancer with radiotherapy-a pan-Canadian survey of radiation oncologists. Curr Oncol (2016) 0.75
Role of adjuvant therapy in early-stage small-cell lung cancer: comment on a population-based cohort study of patients with early-stage small-cell lung cancer. J Thorac Dis (2016) 0.75
Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis. J Thorac Dis (2017) 0.75
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med (2007) 3.39
Diagnosis and management of mycosis fungoides. Oncology (Williston Park) (2010) 2.32
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99
Factors that determine academic versus private practice career interest in radiation oncology residents in the United States: results of a nationwide survey. Int J Radiat Oncol Biol Phys (2013) 1.97
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol (2010) 1.96
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol (2012) 1.84
The pathogenesis of mycosis fungoides. N Engl J Med (2004) 1.78
Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leuk Lymphoma (2006) 1.72
Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol (2011) 1.71
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol (2007) 1.70
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest (2012) 1.60
Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Management of mycosis fungoides: Part 2. Treatment. Oncology (Williston Park) (2003) 1.57
The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol (2005) 1.57
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol (2004) 1.56
Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg (2007) 1.54
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer J (2007) 1.46
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys (2005) 1.44
Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials. Cancer J (2006) 1.41
Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J (2004) 1.39
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol (2002) 1.29
The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol (2010) 1.20
The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol (2015) 1.20
Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16
Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol (2011) 1.16
Total skin electron beam radiotherapy for patients who have mycosis fungoides. Hematol Oncol Clin North Am (2003) 1.13
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys (2007) 1.11
An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 1.08
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther (2009) 1.07
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (2012) 1.06
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma. Arch Dermatol (2009) 1.06
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol (2004) 1.02
Lumping, splitting, and sorting. J Thorac Oncol (2007) 1.01
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. Int J Radiat Oncol Biol Phys (2005) 1.01
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg (2013) 0.98
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 0.98
FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol (2008) 0.97
Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg (2011) 0.95
A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage. J Thorac Oncol (2010) 0.95
Multifocal right atrial myxoma and pulmonary embolism. Ann Thorac Surg (2003) 0.95
Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol (2015) 0.94
Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary? Ann Thorac Surg (2004) 0.94
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol (2010) 0.94
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res (2013) 0.93
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med (2014) 0.93
Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92
Cutaneous lymphoma. Curr Probl Cancer (2008) 0.91
Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer (2012) 0.91
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.91
Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys (2011) 0.91
Looking in from above and up from below: new vistas in thoracic surgery. Innovations (Phila) (2012) 0.90
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS). Support Care Cancer (2008) 0.90
Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex. Am J Clin Oncol (2013) 0.90
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.90
Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. Cancer (2011) 0.90
Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol (2015) 0.90
A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol (2014) 0.89
The fable of Babel and building a foundation for quality. J Thorac Oncol (2012) 0.89
Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest (2013) 0.89
Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. J Clin Oncol (2008) 0.89
Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys (2012) 0.88
Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis. Oncology (Williston Park) (2003) 0.87
Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys (2012) 0.87
Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg (2013) 0.87